Evidence map›Paper›PMID 37774011›Full record

Trial reportAmerican journal of respiratory and critical care medicine2023

High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial.

Raffaele Di Fenza, Naman S Shetty, Stefano Gianni, Vibhu Parcha, Valentina Giammatteo, Bijan Safaee Fakhr, Daniel Tornberg, Olof Wall, Piotr Harbut, Peggy S Lai and 15 more

Open access · hybridAbstract readRandomized Controlled TrialMulticenter StudyClinical Trial, Phase II
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Beyond vasodilation: reframing inhaled nitric oxide as a precision therapy.American journal of respiratory and critical care medicine · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 2 countries.

Raffaele Di FenzaDepartment of Anesthesia, Critical Care, and Pain Medicine.ORCID 0000-0002-5675-7139
Naman S ShettyDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Stefano GianniDepartment of Anesthesia, Critical Care, and Pain Medicine.ORCID 0000-0002-0838-3654
Vibhu ParchaDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Valentina GiammatteoDepartment of Anesthesia, Critical Care, and Pain Medicine.
Bijan Safaee FakhrDepartment of Anesthesia, Critical Care, and Pain Medicine.
Daniel TornbergDepartment of Clinical Sciences and.
Olof WallDepartment of Clinical Sciences and.
Piotr HarbutDepartment of Clinical Sciences and.
Peggy S LaiPulmonary and Critical Care Medicine, Department of Medicine.ORCID 0000-0001-9501-8606
Jonathan Z LiHarvard Medical School, Boston, Massachusetts.
Sabrina PaganoniSean M. Healey and AMG Center for ALS.
Stefano CenciDepartment of Anesthesia, Critical Care, and Pain Medicine.
Ariel L MuellerDepartment of Anesthesia, Critical Care, and Pain Medicine.
Timothy T HouleDepartment of Anesthesia, Critical Care, and Pain Medicine.
Oluwaseun AkejuDepartment of Anesthesia, Critical Care, and Pain Medicine.
Edward A BittnerDepartment of Anesthesia, Critical Care, and Pain Medicine.
Somnath BoseHarvard Medical School, Boston, Massachusetts.
Louie K ScottCritical Care Medicine, Department of Medicine, Louisiana State University Health Shreveport, Shreveport, Louisiana.
Ryan W CarrollDivision of Pediatric Critical Care Medicine, Department of Pediatrics.ORCID 0000-0002-7513-7023
Fumito IchinoseDepartment of Anesthesia, Critical Care, and Pain Medicine.
Magnus HedenstiernaDepartment of Infectious Diseases, Danderyd Hospital, Stockholm, Sweden.
Pankaj AroraDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
Lorenzo BerraDepartment of Anesthesia, Critical Care, and Pain Medicine.ORCID 0000-0003-2702-2093
Nitric Oxide Investigators
Harvard University · USUniversity of Alabama at Birmingham · USBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USDanderyds sjukhus · SEKarolinska Institutet · SELouisiana State University · US

Funding

Harvard Medical School Vaccine Clinical Trials UnitUM1AI069412 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Lindsey Robert Baden, Daniel R. Kuritzkes · 2012 to 2026
$57.2M
NIAID NIH HHS UM1 AI069412
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Respiratory InsufficiencyAdministration, InhalationAdultHumansNitric OxideRespiration, ArtificialSingle-Blind MethodNitric OxideCOVID-19critical illnessnitric oxidepneumoniarespiration, artificialviremia

Identifiers

PMID37774011
PMCPMC10765403
OpenAlexW4387164922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.